Most of us would probably say that the vast majority of our patients are quite satisfied with the care they receive in our offices. But how do we know this for sure?

The U.S. Food and Drug Administration (FDA) recently approved Eylea (afilbercept, Regeneron) for all forms of macular edema after retinal vein occlusion, including branch retinal vein occlusion.

California’s Medicaid program, Medi-Cal, will begin to cover teledenistry services on Jan. 1, 2015, making it one of the first states to do so.

Bono, the iconic Irish rocker and front man for band U2, recently revealed on The Graham Norton Show that he does not wear his avant-garde designer shades for fashion alone.

In his second installment for his Optometry Times blog, The Schachter Factor, Dr. Scott Schachter discusses his protocol for diagnosing and treating dry eye patients in his practice.

A recent survey from Technology Advice found that 25 percent of adults are using a fitness tracker or smartphone app to track their health, weight, or exercise. But according to a report from Venture Beat, physicians are hesitant of the data produced by fitness trackers.

A study published in The British Journal of Ophthalmology found that corneal collagen crosslinking appears to be an effective procedure in the management of superficial microbial keratitis.

After epidemiological studies on the association between vitamin C intake and lung cancer risk produced inconsistent results, researchers conducted a meta-analysis of 21 studies to assess the association.

Ohr Pharmaceutical recently announced details of the planned Phase III registration trials for squalamine eye drops (OHR-102) in the treatment of wet age-related macular degeneration (AMD), which are being designed based on guidance provided by the U.S. Food and Drug Administration (FDA) at a recent "end of Phase II" meeting.

It is with great excitement that we unveil our network-wide redesign. Please read further to learn more about a few of our new features, and browse around to explore the new site!

Where is the research and development in care systems for these patients? Where is the development of new gas permeable materials?

I recently read that the restaurant in Tampa, which licenses the name Hogan’s Beach from the professional wrestler Hulk Hogan, is under fire for its controversial dress code. One area of concern for us optometrist is the fourth item on this controversial dress code: “No excessively baggy attire.” You may be questioning how this is germane to comanagement or, frankly, what this has to do with the doctoring of the eyes.

When the retina in my left eye detached in early October 2013, I was on a tour bus, somewhere between Canter’s Deli and Griffith Observatory, in Los Angeles. There was a series of flashes, like warning flares, and then a black tide, an oil slick of a blind spot that started down and to the left and crept toward the center of my vision, arcs of lightning heralding its advance. I knew what was happening, but I didn’t want to believe it.

Alcon recently launched Toric Pro, a new app that gives cataract surgeons a number of tools in a single app intended to improve their knowledge on toric IOL procedures for treating astigmatism at the time of surgery.

SynergEyes, Inc. has expanded parameters for its Duette Progressive lens, which is now available in 0.1 mm increments.

Reichert Technologies recently released the new Xcel 455 Slit Lamp, a traditional style slit lamp with tower illumination and five-step magnification.

With Halloween just around the corner, your patients may be looking for something to enhance their costumes, but if they purchase illegal cosmetic contact lenses, they can expect problems long after trick-or-treat.

Researchers at Glasgow Caledonian University (GCU) are developing a way to use video games to improve the eyesight of children with amblyopia.

A recent study from researchers at Tel Aviv University published in Vision Research found that a test examining involuntary eye movements may help diagnose attention deficit/hyperactive disorder (ADHD) and can predict whether stimulant medication would be an effective treatment for the individual.

Researchers at National Taiwan University Hospital have developed a wearable optical device that can detect sluggish pupil reaction, a symptom of diabetic autonomic neuropathy.